APO Research
Talk to an analyst

APO RESEARCH · REPORT

Type 2 Diabetes Mellitus Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Type 2 Diabetes Mellitus Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025185 pages

Choose your research edition.

Industry ResearchType 2 Diabetes Mellitus Treatment Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 2 Diabetes Mellitus Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Type 2 Diabetes Mellitus Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 2 Diabetes Mellitus Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 2 Diabetes Mellitus Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Type 2 Diabetes Mellitus Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Type 2 Diabetes Mellitus Treatment include Takeda Pharmaceutical Co. Ltd, Sanofi SA, Novartis AG, Novo Nordisk AS, Merck & Co. Inc, Eli Lilly and Co., Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH and AstraZeneca PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Type 2 Diabetes Mellitus Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Type 2 Diabetes Mellitus Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Type 2 Diabetes Mellitus Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Type 2 Diabetes Mellitus Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Type 2 Diabetes Mellitus Treatment Segment by Company

Takeda Pharmaceutical Co. Ltd

Sanofi SA

Novartis AG

Novo Nordisk AS

Merck & Co. Inc

Eli Lilly and Co.

Daiichi Sankyo Co. Ltd

Boehringer Ingelheim International GmbH

AstraZeneca PLC

Type 2 Diabetes Mellitus Treatment Segment by Type

Insulin

SGLT2 Inhibitors

GLP-1 Receptor Agonists

DPP-4 Inhibitors

Others

Type 2 Diabetes Mellitus Treatment Segment by Application

Hospitals

Clinics

Other

Type 2 Diabetes Mellitus Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes Mellitus Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes Mellitus Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes Mellitus Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Type 2 Diabetes Mellitus Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Type 2 Diabetes Mellitus Treatment industry.

Chapter 3: Detailed analysis of Type 2 Diabetes Mellitus Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Type 2 Diabetes Mellitus Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Insulin Table 3. Key Players of SGLT2 Inhibitors Table 4. Key Players of GLP-1 Receptor Agonists Table 3. Key Players of DPP-4 Inhibitors Table 4. Key Players of Others Table 5. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals Table 7. Key Players of Clinics Table 8. Key Players of Other Table 9. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2021-2026) Table 12. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2027-2032) Table 14. Type 2 Diabetes Mellitus Treatment Industry Trends Table 15. Type 2 Diabetes Mellitus Treatment Industry Drivers Table 16. Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges Table 17. Type 2 Diabetes Mellitus Treatment Industry Restraints Table 18. Global Type 2 Diabetes Mellitus Treatment Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Company (2021-2026) Table 20. Global Type 2 Diabetes Mellitus Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Type 2 Diabetes Mellitus Treatment Key Company Head Office and Area Served Table 22. Global Type 2 Diabetes Mellitus Treatment Company, Product Type & Application Table 23. Global Type 2 Diabetes Mellitus Treatment Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Type 2 Diabetes Mellitus Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Type 2 Diabetes Mellitus Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Type 2 Diabetes Mellitus Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2027-2032) Table 36. Takeda Pharmaceutical Co. Ltd Company Information Table 37. Takeda Pharmaceutical Co. Ltd Business Overview Table 38. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 40. Takeda Pharmaceutical Co. Ltd Recent Development Table 41. Sanofi SA Company Information Table 42. Sanofi SA Business Overview Table 43. Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio Table 45. Sanofi SA Recent Development Table 46. Novartis AG Company Information Table 47. Novartis AG Business Overview Table 48. Novartis AG Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio Table 50. Novartis AG Recent Development Table 51. Novo Nordisk AS Company Information Table 52. Novo Nordisk AS Business Overview Table 53. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio Table 55. Novo Nordisk AS Recent Development Table 56. Merck & Co. Inc Company Information Table 57. Merck & Co. Inc Business Overview Table 58. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio Table 60. Merck & Co. Inc Recent Development Table 61. Eli Lilly and Co. Company Information Table 62. Eli Lilly and Co. Business Overview Table 63. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio Table 65. Eli Lilly and Co. Recent Development Table 66. Daiichi Sankyo Co. Ltd Company Information Table 67. Daiichi Sankyo Co. Ltd Business Overview Table 68. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 70. Daiichi Sankyo Co. Ltd Recent Development Table 71. Boehringer Ingelheim International GmbH Company Information Table 72. Boehringer Ingelheim International GmbH Business Overview Table 73. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio Table 75. Boehringer Ingelheim International GmbH Recent Development Table 76. AstraZeneca PLC Company Information Table 77. AstraZeneca PLC Business Overview Table 78. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio Table 80. AstraZeneca PLC Recent Development Table 81. North America Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 82. North America Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032) & (US$ Million) Table 83. North America Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 84. North America Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032) & (US$ Million) Table 85. North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 86. North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) Table 87. North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032) Table 88. Europe Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 89. Europe Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032) & (US$ Million) Table 90. Europe Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 91. Europe Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032) & (US$ Million) Table 92. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) Table 94. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032) Table 95. China Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 96. China Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032) & (US$ Million) Table 97. China Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 98. China Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 100. Asia Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032) & (US$ Million) Table 101. Asia Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 102. Asia Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Asia Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) Table 105. Asia Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032) Table 106. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026) & (US$ Million) Table 107. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032) & (US$ Million) Table 108. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026) Table 112. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Type 2 Diabetes Mellitus Treatment Product Image Figure 2. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Type 2 Diabetes Mellitus Treatment Market Share by Type: 2025 VS 2032 Figure 4. Insulin Image Figure 5. SGLT2 Inhibitors Image Figure 6. GLP-1 Receptor Agonists Image Figure 7. DPP-4 Inhibitors Image Figure 8. Others Image Figure 9. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Type 2 Diabetes Mellitus Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Other Image Figure 14. Global Type 2 Diabetes Mellitus Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 16. Global Type 2 Diabetes Mellitus Treatment Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Type 2 Diabetes Mellitus Treatment Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Type 2 Diabetes Mellitus Treatment Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 26. North America Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032) Figure 27. North America Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032) Figure 28. North America Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 29. United States Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Canada Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032) Figure 34. Europe Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032) Figure 35. Europe Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 36. Germany Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 37. France Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Italy Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Russia Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032) Figure 44. China Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032) Figure 45. Asia Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 46. Asia Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032) Figure 47. Asia Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032) Figure 48. Asia Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 49. Japan Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 53. India Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Australia Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032) Figure 59. Brazil Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 64. UAE Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Chile Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • SGLT2 Inhibitors
  • GLP-1 Receptor Agonists
  • DPP-4 Inhibitors
  • Others
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Co. Ltd
  • Sanofi SA
  • Novartis AG
  • Novo Nordisk AS
  • Merck & Co. Inc
  • Eli Lilly and Co.
  • Daiichi Sankyo Co. Ltd
  • Boehringer Ingelheim International GmbH
  • AstraZeneca PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin
  5. 1.2.3 SGLT2 Inhibitors
  6. 1.2.4 GLP-1 Receptor Agonists
  7. 1.2.5 DPP-4 Inhibitors
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.3.4 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Type 2 Diabetes Mellitus Treatment Growth Trends by Region
  16. 1.5.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Type 2 Diabetes Mellitus Treatment Market Size by Region (2021-2026)
  18. 1.5.3 Type 2 Diabetes Mellitus Treatment Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Type 2 Diabetes Mellitus Treatment Market Dynamics
  1. 2.1 Type 2 Diabetes Mellitus Treatment Industry Trends
  2. 2.2 Type 2 Diabetes Mellitus Treatment Industry Drivers
  3. 2.3 Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges
  4. 2.4 Type 2 Diabetes Mellitus Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Type 2 Diabetes Mellitus Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Type 2 Diabetes Mellitus Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Type 2 Diabetes Mellitus Treatment Key Company Head office and Area Served
  4. 3.4 Global Type 2 Diabetes Mellitus Treatment Company, Product Type & Application
  5. 3.5 Global Type 2 Diabetes Mellitus Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Type 2 Diabetes Mellitus Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Type 2 Diabetes Mellitus Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Type 2 Diabetes Mellitus Treatment Tier 1, Tier 2, and Tier 3
4 Type 2 Diabetes Mellitus Treatment Market by Type
  1. 4.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Type 2 Diabetes Mellitus Treatment Market Size Share by Type (2021-2032)
5 Type 2 Diabetes Mellitus Treatment Market by Application
  1. 5.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Type 2 Diabetes Mellitus Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Co. Ltd
  2. 6.1.1 Takeda Pharmaceutical Co. Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Co. Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Co. Ltd Recent Developments
  7. 6.2 Sanofi SA
  8. 6.2.1 Sanofi SA Company Information
  9. 6.2.2 Sanofi SA Business Overview
  10. 6.2.3 Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio
  12. 6.2.5 Sanofi SA Recent Developments
  13. 6.3 Novartis AG
  14. 6.3.1 Novartis AG Company Information
  15. 6.3.2 Novartis AG Business Overview
  16. 6.3.3 Novartis AG Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio
  18. 6.3.5 Novartis AG Recent Developments
  19. 6.4 Novo Nordisk AS
  20. 6.4.1 Novo Nordisk AS Company Information
  21. 6.4.2 Novo Nordisk AS Business Overview
  22. 6.4.3 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio
  24. 6.4.5 Novo Nordisk AS Recent Developments
  25. 6.5 Merck & Co. Inc
  26. 6.5.1 Merck & Co. Inc Company Information
  27. 6.5.2 Merck & Co. Inc Business Overview
  28. 6.5.3 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio
  30. 6.5.5 Merck & Co. Inc Recent Developments
  31. 6.6 Eli Lilly and Co.
  32. 6.6.1 Eli Lilly and Co. Company Information
  33. 6.6.2 Eli Lilly and Co. Business Overview
  34. 6.6.3 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio
  36. 6.6.5 Eli Lilly and Co. Recent Developments
  37. 6.7 Daiichi Sankyo Co. Ltd
  38. 6.7.1 Daiichi Sankyo Co. Ltd Company Information
  39. 6.7.2 Daiichi Sankyo Co. Ltd Business Overview
  40. 6.7.3 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  42. 6.7.5 Daiichi Sankyo Co. Ltd Recent Developments
  43. 6.8 Boehringer Ingelheim International GmbH
  44. 6.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 6.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 6.8.3 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio
  48. 6.8.5 Boehringer Ingelheim International GmbH Recent Developments
  49. 6.9 AstraZeneca PLC
  50. 6.9.1 AstraZeneca PLC Company Information
  51. 6.9.2 AstraZeneca PLC Business Overview
  52. 6.9.3 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio
  54. 6.9.5 AstraZeneca PLC Recent Developments
7 North America
  1. 7.1 North America Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  2. 7.2 North America Type 2 Diabetes Mellitus Treatment Market Size by Type
  3. 7.2.1 North America Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Type 2 Diabetes Mellitus Treatment Market Size by Application
  7. 7.3.1 North America Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Type 2 Diabetes Mellitus Treatment Market Size by Country
  11. 7.4.1 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  2. 8.2 Europe Type 2 Diabetes Mellitus Treatment Market Size by Type
  3. 8.2.1 Europe Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Type 2 Diabetes Mellitus Treatment Market Size by Application
  7. 8.3.1 Europe Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country
  11. 8.4.1 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  2. 9.2 China Type 2 Diabetes Mellitus Treatment Market Size by Type
  3. 9.2.1 China Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032)
  6. 9.3 China Type 2 Diabetes Mellitus Treatment Market Size by Application
  7. 9.3.1 China Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  2. 10.2 Asia Type 2 Diabetes Mellitus Treatment Market Size by Type
  3. 10.2.1 Asia Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Type 2 Diabetes Mellitus Treatment Market Size by Application
  7. 10.3.1 Asia Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Type 2 Diabetes Mellitus Treatment Market Size by Country
  11. 10.4.1 Asia Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst